Artal Group’s Dimension Therapeutics, Inc DMTX Stock Holding History

Artal Group’s Portfolio DMTX Stock Details DMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-234,493	Closed	-$1.41M	–	139
2017 Q3	$1.41M	Hold	234,493	–	–	0.02%	101
2017 Q2	$340K	Hold	234,493	–	–	0.01%	108
2017 Q1	$410K	Hold	234,493	–	–	0.01%	95
2016 Q4	$1.02M	Hold	234,493	–	–	0.02%	86
2016 Q3	$1.87M	Sell	234,493 -40,507	-15%	-$293K	0.04%	85
2016 Q2	$1.65M	Hold	275,000	–	–	0.03%	62
2016 Q1	$2.15M	Buy	275,000 +100,000	+57%	+$788K	0.04%	52
2015 Q4	$1.97M	Buy	+175,000	New	+$2.21M	0.04%	74

Artal Group's DMTX Position: Q4 2017 in Review

Artal Group sold out of Dimension Therapeutics, Inc (DMTX) in Q4 2017, closing a stake of 234,493 shares — an estimated $1.41M sold.

Artal Group first reported a position in DMTX in Q4 2015 and held it in 8 quarters. The position peaked at $2.15M in Q1 2016. 0 funds tracked by Wall St. Rank hold DMTX as of Q4 2017.

Artal Group reported no remaining Dimension Therapeutics, Inc position as of Q4 2017 after selling out during the quarter.
Artal Group sold 234,493 Dimension Therapeutics, Inc shares in Q4 2017, an estimated $1.41M.
Artal Group first reported a position in Dimension Therapeutics, Inc in Q4 2015 and held it in 8 quarters.
Artal Group's Dimension Therapeutics, Inc position peaked at $2.15M in Q1 2016.
0 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2017.

Based on Artal Group's 13F filing for Q4 2017, filed 9 Feb 2018.